Terms: = Liver cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Treatment
332 results:
1. il-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.
Roser LA; Sakellariou C; Lindstedt M; Neuhaus V; Dehmel S; Sommer C; Raasch M; Flandre T; Roesener S; Hewitt P; Parnham MJ; Sewald K; Schiffmann S
J Immunotoxicol; 2024 Dec; 21(1):2332177. PubMed ID: 38578203
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma.
Xu Y; Sun F; Tian Y; Zeng G; Lei G; Bai Z; Wang Y; Ge X; Wang J; Xiao C; Wang Z; Hu M; Song J; Yang P; Liu R
Int Immunopharmacol; 2024 Mar; 129():111628. PubMed ID: 38320351
[TBL] [Abstract] [Full Text] [Related]
3. Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases.
Li CMY; Tomita Y; Dhakal B; Tin T; Li R; Wright JA; Vrbanac L; Woods SL; Drew P; Price T; Smith E; Maddern GJ; Fenix K
Cancer Immunol Immunother; 2024 Jan; 73(1):6. PubMed ID: 38231291
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Effect of the Combination of Compound Kushen Injection and Gemcitabine on Postoperative Patients with Non-Muscle Invasive Bladder cancer and Its Influence on Serum-Related Factors.
Dong X; Wang Y; Wang S; Li C; Zhang M; Hou F
Arch Esp Urol; 2023 Nov; 76(9):657-665. PubMed ID: 38053420
[TBL] [Abstract] [Full Text] [Related]
5. Mechanism Research and Application for Ginsenosides in the treatment of Hepatocellular Carcinoma.
Zhou N; Mao F; Cheng S
Biomed Res Int; 2023; 2023():7214037. PubMed ID: 38027042
[TBL] [Abstract] [Full Text] [Related]
6. Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.
Mahdi HS; Woodall-Jappe M; Singh P; Czuczman MS
Front Immunol; 2023; 14():1268979. PubMed ID: 38022532
[TBL] [Abstract] [Full Text] [Related]
7. Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy.
Chiang J; Chen PC; Pham J; Nguyen CQ; Kaur K; Raman SS; Jewett A
Front Immunol; 2023; 14():1284669. PubMed ID: 37954598
[TBL] [Abstract] [Full Text] [Related]
8. Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Borcoman E; Lalanne A; Delord JP; Cassier PA; Rolland F; Salas S; Limacher JM; Capitain O; Lantz O; Ekwegbara C; Jeannot E; Cyrta J; Tran-Perennou C; Castel-Ajgal Z; Marret G; Piaggio E; Brandely M; Tavernaro A; Makhloufi H; Bendjama K; Le Tourneau C
Eur J Cancer; 2023 Sep; 191():112981. PubMed ID: 37506588
[TBL] [Abstract] [Full Text] [Related]
9. Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic liver cancer.
Jiang H; Fu H; Min T; Hu P; Shi J
J Am Chem Soc; 2023 Jun; 145(24):13147-13160. PubMed ID: 37262421
[TBL] [Abstract] [Full Text] [Related]
10. Switchable hepatic organelles aberrations in DEN-induced mice under the influence of chemically characterized silk sericin.
Bakr BA; Sadek IA; El-Samad LM; El Wakil A
Tissue Cell; 2023 Jun; 82():102101. PubMed ID: 37141749
[TBL] [Abstract] [Full Text] [Related]
11. Conjugating 4β-NH-(5-Aminoindazole)-podophyllotoxin and Galectin-1-Targeted Aptamer for Synergistic Chemo-Immunotherapy of Hepatocellular Carcinoma.
Cong Y; Zhang SY; Tang PY; Li HM; Liu X; Zhao W; Tang YJ
Adv Healthc Mater; 2023 Sep; 12(22):e2203144. PubMed ID: 37141264
[TBL] [Abstract] [Full Text] [Related]
12. Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of cancer Transmission.
Greenhall GHB; Rous BA; Robb ML; Brown C; Hardman G; Hilton RM; Neuberger JM; Dark JH; Johnson RJ; Forsythe JLR; Tomlinson LA; Callaghan CJ; Watson CJE
JAMA Surg; 2023 May; 158(5):504-513. PubMed ID: 36947028
[TBL] [Abstract] [Full Text] [Related]
13. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients.
Noordam L; de Beijer MTA; Mancham S; Vogler I; Boor PPC; de Ruiter V; Luijten R; IJzermans JNM; Sahin U; Bruno MJ; Sprengers D; Buschow SI; Kwekkeboom J
Oncoimmunology; 2022; 11(1):2131096. PubMed ID: 36211805
[TBL] [Abstract] [Full Text] [Related]
14. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition.
Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB
Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708
[TBL] [Abstract] [Full Text] [Related]
15. Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel.
Porter TJ; Lazarevic A; Ziggas JE; Fuchs E; Kim K; Byrnes H; Luznik L; Bolaños-Meade J; Ali SA; Shah NN; Wagner-Johnston N; Jain T
Br J Haematol; 2022 Dec; 199(5):720-727. PubMed ID: 36111395
[TBL] [Abstract] [Full Text] [Related]
16. Immunomodulatory roles of propofol and sevoflurane in murine models of breast cancer.
Yan R; Song T; Wang W; Tian J; Ma X
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):153-159. PubMed ID: 36073191
[TBL] [Abstract] [Full Text] [Related]
17. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
[TBL] [Abstract] [Full Text] [Related]
18. Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.
Song Q; Nasri U; Nakamura R; Martin PJ; Zeng D
Front Immunol; 2022; 13():907673. PubMed ID: 35677056
[TBL] [Abstract] [Full Text] [Related]
19. Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease.
Kim HT; Koreth J; Whangbo J; Nikiforow S; Reynolds CG; Stowe P; Ho VT; Cutler C; Antin JH; Soiffer RJ; Ritz J
Blood Adv; 2022 Aug; 6(15):4392-4402. PubMed ID: 35617682
[TBL] [Abstract] [Full Text] [Related]
20. [Therapeutic effect of
Zou Q; Wu X; Wang J; Xia D; Deng M; Ding Y; Dai Y; Zhao S; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):538-545. PubMed ID: 35527489
[TBL] [Abstract] [Full Text] [Related]
[Next]
